SUTRO BIOPHARMA INC (STRO) Stock Earnings & Estimates
USA - NASDAQ:STRO - US8693671021 - Common Stock
0.877 USD
+0.05 (+5.87%)
0.877 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 67.77M 9.52% | 153.731M 126.84% | 62.043M -59.64% | 102.67M 65.48% | 63.751M -37.91% | 53.304M -16.39% | 53.945M 1.20% | 66.901M 24.02% | 70.327M 5.12% | 92.971M 32.20% | 95.068M 2.26% | |
| EBITDA YoY % growth | -123.25M -31.56% | -82.462M 33.09% | -231.235M -180.41% | -106.565M 53.92% | -31.911M 70.06% | -104.244M -226.67% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -128.94M -30.88% | -89.278M 30.76% | -238.453M -167.09% | -139.133M 41.65% | -101.502M 27.05% | -103.899M -2.36% | -84.959M 18.23% | -70.111M 17.48% | -59.374M 15.31% | -25.174M 57.60% | -9.745M 61.29% | |
| Operating Margin | -190.26% | -58.07% | -384.34% | -135.51% | -159.22% | -194.92% | -157.49% | -104.80% | -84.43% | -27.08% | -10.25% | |
| EPS YoY % growth | -2.44 -6.55% | -1.78 27.05% | -3.02 -69.66% | -1.97 34.69% | -1.24 37.06% | -1.20 3.22% | -0.13 88.96% | -0.09 30.77% | -0.06 33.33% | -0.03 50.00% | 0.00 100.00% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.43 27.58% | -0.45 49.32% | -0.44 51.80% | -0.43 -207.82% | -0.45 -5.04% | -0.50 -11.37% |
| Revenue Q2Q % growth | 9.274M 8.85% | 8.666M -41.48% | 11.798M -32.19% | 11.9M -81.33% | 11.662M 25.75% | 11.798M 36.14% |
| EBITDA Q2Q % growth | -29.453M 52.93% | -25.679M 55.76% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -36.069M 46.89% | -37.072M 43.19% | -36.159M 23.83% | -37.689M -349.98% | -39.729M -10.15% | -42.024M -13.36% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.14 76.27% | -0.41 | 0.27 | 65.88% |
| Q1 2025 Q2Q % growth | -0.91 4.21% | -0.72 | -0.19 | -26.10% |
| Q4 2024 Q2Q % growth | -0.89 -271.15% | -0.85 | -0.04 | -4.99% |
| Q3 2024 Q2Q % growth | -0.59 27.16% | -0.75 | 0.16 | 21.27% |
| Q2 2024 Q2Q % growth | -0.59 7.81% | -0.81 | 0.22 | 26.97% |
| Q1 2024 Q2Q % growth | -0.95 -11.76% | -0.94 | -0.01 | -1.02% |
| Q4 2023 Q2Q % growth | 0.52 176.47% | -0.84 | 1.36 | 161.92% |
| Q3 2023 Q2Q % growth | -0.81 -118.92% | -0.75 | -0.06 | -7.90% |
| Q2 2023 Q2Q % growth | -0.64 -16.36% | -0.75 | 0.11 | 14.34% |
| Q1 2023 Q2Q % growth | -0.85 -1.19% | -0.83 | -0.02 | -2.70% |
| Q4 2022 Q2Q % growth | -0.68 18.07% | -0.63 | -0.05 | -7.31% |
| Q3 2022 Q2Q % growth | -0.37 44.78% | -0.75 | 0.38 | 50.87% |
| Q2 2022 Q2Q % growth | -0.55 -323.08% | -0.47 | -0.08 | -16.86% |
| Q1 2022 Q2Q % growth | -0.84 -27.27% | -0.77 | -0.07 | -8.72% |
| Q4 2021 Q2Q % growth | -0.83 43.92% | -0.70 | -0.13 | -18.15% |
| Q3 2021 Q2Q % growth | -0.67 -248.89% | -0.66 | -0.01 | -0.86% |
| Q2 2021 Q2Q % growth | -0.13 77.97% | -0.42 | 0.29 | 69.20% |
| Q1 2021 Q2Q % growth | -0.66 21.43% | -0.62 | -0.04 | -7.28% |
| Q4 2020 Q2Q % growth | -1.48 -131.25% | -0.58 | -0.90 | -154.56% |
| Q3 2020 Q2Q % growth | 0.45 180.36% | -0.52 | 0.97 | 186.99% |
| Q2 2020 Q2Q % growth | -0.59 1.67% | -0.66 | 0.07 | 10.15% |
| Q1 2020 Q2Q % growth | -0.84 -35.48% | -0.70 | -0.14 | -19.60% |
| Q4 2019 Q2Q % growth | -0.64 | -0.71 | 0.07 | 9.56% |
| Q3 2019 Q2Q % growth | -0.56 | -0.67 | 0.11 | 16.09% |
| Q2 2019 Q2Q % growth | -0.60 | -0.69 | 0.09 | 13.18% |
| Q1 2019 Q2Q % growth | -0.62 | -0.65 | 0.03 | 4.28% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 63.745M 147.98% | 14.538M | 49.207M | 338.47% |
| Q1 2025 Q2Q % growth | 17.399M 33.76% | 11.843M | 5.556M | 46.91% |
| Q4 2024 Q2Q % growth | 14.809M -86.98% | 12.685M | 2.124M | 16.74% |
| Q3 2024 Q2Q % growth | 8.52M -49.66% | 15.558M | -7.038M | -45.24% |
| Q2 2024 Q2Q % growth | 25.706M 146.89% | 21.441M | 4.265M | 19.89% |
| Q1 2024 Q2Q % growth | 13.008M 2.64% | 12.312M | 696K | 5.65% |
| Q4 2023 Q2Q % growth | 113.721M 1,217.74% | 12.044M | 101.677M | 844.21% |
| Q3 2023 Q2Q % growth | 16.924M -32.71% | 13.259M | 3.665M | 27.64% |
| Q2 2023 Q2Q % growth | 10.412M -62.95% | 12.808M | -2.396M | -18.71% |
| Q1 2023 Q2Q % growth | 12.674M 114.81% | 11.373M | 1.301M | 11.44% |
| Q4 2022 Q2Q % growth | 8.63M -18.97% | 14.768M | -6.138M | -41.56% |
| Q3 2022 Q2Q % growth | 25.15M 195.19% | 12.932M | 12.218M | 94.48% |
| Q2 2022 Q2Q % growth | 28.1M 0.18% | 17.021M | 11.079M | 65.09% |
| Q1 2022 Q2Q % growth | 5.9M -59.75% | 10.675M | -4.775M | -44.73% |
| Q4 2021 Q2Q % growth | 10.65M 28.62% | 10.865M | -215K | -1.98% |
| Q3 2021 Q2Q % growth | 8.52M -52.19% | 9.148M | -628K | -6.86% |
| Q2 2021 Q2Q % growth | 28.05M 196.20% | 13.605M | 14.445M | 106.17% |
| Q1 2021 Q2Q % growth | 14.66M 105.03% | 5.843M | 8.817M | 150.90% |
| Q4 2020 Q2Q % growth | 8.28M -26.79% | 9.575M | -1.295M | -13.52% |
| Q3 2020 Q2Q % growth | 17.82M 45.11% | 8.67M | 9.15M | 105.54% |
| Q2 2020 Q2Q % growth | 9.47M -10.07% | 8.128M | 1.342M | 16.51% |
| Q1 2020 Q2Q % growth | 7.15M -17.15% | 10.909M | -3.759M | -34.46% |
| Q4 2019 Q2Q % growth | 11.31M | 10.158M | 1.152M | 11.34% |
| Q3 2019 Q2Q % growth | 12.28M | 10.062M | 2.218M | 22.04% |
| Q2 2019 Q2Q % growth | 10.53M | 8.555M | 1.975M | 23.09% |
| Q1 2019 Q2Q % growth | 8.63M | 9.022M | -392K | -4.34% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -35.69% | 0% | -4.91% |
| Revenue | 1.11% | -32.51% | 0.04% | 77.92% |